News
Immix Biopharma, Inc. (NASDAQ:IMMX) IMX-110 + anti-PD-1 produced 63-day median survival in a genetic (KPC) pancreatic cancer mouse model in which mice develop their own pancreatic cancer and have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback